Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
2023 Don’t Talk-A-Thon
https://vimeo.com/819587542?share=copy Alex Cavaliere, Her ALS Story Each year during May-ALS Awareness Month-we ask people to take a vow of silence to honor those who have